Clinical Trials
7 trialsNCT02943642 2026-05-18
Resimmune®
Virogen Biotechnology Inc.
Phase 2 Withdrawn
NCT07195916 2026-05-04
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Phase 1 Recruiting
NCT03902184 2026-04-29
TELLOMAK
Innate Pharma
Phase 2 Completed
NCT06854653 2026-04-29
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Prescient Therapeutics, Ltd.
Phase 2 Recruiting
NCT02732275 2026-04-28
DS-3201b in Participants With Lymphomas
Daiichi Sankyo
Phase 1 Active not recruiting
NCT07192471 2026-04-20
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Phase 1 Not yet recruiting
NCT06470451 2026-04-03
FLASH2
Soligenix
Phase 3 Recruiting